{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:29:05Z","timestamp":1775150945321,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ejphar.2022.174841","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T10:55:52Z","timestamp":1646823352000},"page":"174841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR\/SHP\/SREBP-1c axis"],"prefix":"10.1016","volume":"921","author":[{"given":"Ankang","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zejiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0181-2927","authenticated-orcid":false,"given":"Yingkun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0627-9968","authenticated-orcid":false,"given":"Rong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.174841_bib1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.metabol.2015.11.008","article-title":"Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"65","author":"Brown","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2022.174841_bib2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2022.174841_bib3","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2022.174841_bib4","doi-asserted-by":"crossref","first-page":"9293","DOI":"10.3390\/molecules18089293","article-title":"Anti-oxidant and anti-inflammatory activities of Inonotus obliquus and germinated brown rice extracts","volume":"18","author":"Debnath","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2022.174841_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.phymed.2018.09.006","article-title":"Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor","volume":"53","author":"Dong","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2022.174841_bib6","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/ptr.6384","article-title":"The pharmacological potential and possible molecular mechanisms of action of Inonotus obliquus from preclinical studies","volume":"33","author":"Duru","year":"2019","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2022.174841_bib7","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.carbpol.2012.06.013","article-title":"Antitumor and immunomodulatory activity of water-soluble polysaccharide from Inonotus obliquus","volume":"90","author":"Fan","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejphar.2022.174841_bib8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2022.174841_bib9","doi-asserted-by":"crossref","first-page":"108794","DOI":"10.1016\/j.cbi.2019.108794","article-title":"Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR\/LXRs-dependent manner","volume":"311","author":"Han","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2022.174841_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijbiomac.2016.03.006","article-title":"Antioxidant activity of Inonotus obliquus polysaccharide and its amelioration for chronic pancreatitis in mice","volume":"87","author":"Hu","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejphar.2022.174841_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41419-020-2472-6","article-title":"Neddylation of sterol regulatory element-binding protein 1c is a potential therapeutic target for nonalcoholic fatty liver treatment","volume":"11","author":"Ju","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2022.174841_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lfs.2005.12.047","article-title":"Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus","volume":"79","author":"Kim","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2022.174841_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","article-title":"The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome","volume":"7","author":"Lim","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2022.174841_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41401-019-0228-6","article-title":"CB-Dock: a web server for cavity detection-guided protein-ligand blind docking","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2022.174841_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.foodchem.2013.01.030","article-title":"Anti-inflammatory and anticancer activities of extracts and compounds from the mushroom Inonotus obliquus","volume":"139","author":"Ma","year":"2013","journal-title":"Food Chem."},{"key":"10.1016\/j.ejphar.2022.174841_bib16","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","author":"Machado","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.174841_bib17","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.3390\/ijms13079194","article-title":"Antioxidative properties of crude polysaccharides from Inonotus obliquus","volume":"13","author":"Mu","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.174841_bib18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1128\/MCB.23.3.864-872.2003","article-title":"Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol","volume":"23","author":"Otte","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2022.174841_bib19","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.174841_bib20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1172\/JCI88893","article-title":"Nutrient-sensing nuclear receptors PPAR\u03b1 and FXR control liver energy balance","volume":"127","author":"Preidis","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2022.174841_bib21","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2022.174841_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1084\/jem.20171965","article-title":"Bile acids in glucose metabolism in health and disease","volume":"215","author":"Shapiro","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2022.174841_bib23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fmed.2020.00544","article-title":"Bile acids and FXR: novel targets for liver diseases","volume":"7","author":"Stofan","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.ejphar.2022.174841_bib24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2022.174841_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jtcme.2020.08.003","article-title":"Inonotus obliquus - from folk medicine to clinical use","volume":"11","author":"Szychowski","year":"2021","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.ejphar.2022.174841_bib26","first-page":"212","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease. Gut. TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice","volume":"11","author":"Trauner","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2022.174841_bib28","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.biopha.2017.09.104","article-title":"Anti-diabetic effects of Inonotus obliquus polysaccharides in streptozotocin-induced type 2 diabetic mice and potential mechanism via PI3K-Akt signal pathway","volume":"95","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2022.174841_bib29","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.174841_bib30","article-title":"Bioactive mushroom polysaccharides: a review on monosaccharide composition, biosynthesis and regulation","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2022.174841_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.fct.2016.06.011","article-title":"NF-E2-related factor 2 deletion facilitates hepatic fatty acids metabolism disorder induced by high-fat diet via regulating related genes in mice","volume":"94","author":"Wang","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2022.174841_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(16)30011-5","article-title":"Pathogenesis and novel treatment options for non-alcoholic steatohepatitis","volume":"1","author":"Wong","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2022.174841_bib33","doi-asserted-by":"crossref","first-page":"109609","DOI":"10.1016\/j.biopha.2019.109609","article-title":"Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease","volume":"121","author":"Xi","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2022.174841_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.biopha.2018.05.135","article-title":"Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice","volume":"105","author":"Yan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2022.174841_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922001029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922001029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:02:16Z","timestamp":1757977336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":34,"alternative-id":["S0014299922001029"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.174841","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR\/SHP\/SREBP-1c axis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.174841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174841"}}